Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Mundipharma International seeks products in analgesia, anesthesia and oncology to market through a pan-European sales force. More
Zambon Group is a privately-held multinational pharmaceutical company that in-licenses pharmaceutical products from the discovery to late stage development or already on the market. More
Fresenius Kabi is Europe's leading company in the field of infusion and nutrition therapies for seriously-ill and chronically-ill patients. More
BiotechEast is a one-stop, full-service marketing consultancy for those looking to take advantage of the dynamic opportunities in Taiwan's burgeoning life science industry. More
Lipocine develop branded products using its proprietary drug delivery technologies. They provide discovery and delivery support for challenging drugs. They issued 14 patents and corporate partnerships More
Active Biotech AB is a Swedish biotech company focusing on the research and development of pharmaceuticals, primarily for the treatment of autoimmune / inflammatory diseases and cancer. More
The Italian National Institute of Health (ISS) is the main technical-scientific organ of the Ministry of health and the highest public healthcare research entity in Italy. More
Technology Marketing and Licensing for The University of Nebraska Medical Center More
Camurus provides the global pharma and biotech industry with effective drug delivery technologies for peptides, proteins and insoluble small molecules, for the parenteral, oral and topical routes. More
Novel technological inventions for the prevention and treatment of staphylococcal infections in humans and animals. More
Your selection
Browse By
- Industry sector
- Intravesical
- Nasal
- Nasal topical
- Ophthalmic
- Oral liquid
- Oral solid
- Otic
- Parenteral
- Pulmonary
- Rectal
- Systemic
- Topical
- Vaginal
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us